JP2010529004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529004A5 JP2010529004A5 JP2010509835A JP2010509835A JP2010529004A5 JP 2010529004 A5 JP2010529004 A5 JP 2010529004A5 JP 2010509835 A JP2010509835 A JP 2010509835A JP 2010509835 A JP2010509835 A JP 2010509835A JP 2010529004 A5 JP2010529004 A5 JP 2010529004A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- insulinotropic peptide
- organic solvent
- dehydrated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 230000002473 insulinotropic effect Effects 0.000 claims 6
- 239000003960 organic solvent Substances 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical group C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 238000009472 formulation Methods 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109435 | 2007-06-01 | ||
| EP07109435.3 | 2007-06-01 | ||
| EP07114524 | 2007-08-17 | ||
| EP07114524.7 | 2007-08-17 | ||
| PCT/EP2008/056699 WO2008145732A1 (en) | 2007-06-01 | 2008-05-30 | Stable non-aqueous pharmaceutical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010529004A JP2010529004A (ja) | 2010-08-26 |
| JP2010529004A5 true JP2010529004A5 (cg-RX-API-DMAC7.html) | 2014-03-06 |
| JP5675347B2 JP5675347B2 (ja) | 2015-02-25 |
Family
ID=39764679
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509834A Expired - Fee Related JP5628026B2 (ja) | 2007-06-01 | 2008-05-30 | 安定した非水性薬学的組成物 |
| JP2010509835A Expired - Fee Related JP5675347B2 (ja) | 2007-06-01 | 2008-05-30 | 安定した非水性薬学的組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509834A Expired - Fee Related JP5628026B2 (ja) | 2007-06-01 | 2008-05-30 | 安定した非水性薬学的組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20100190706A1 (cg-RX-API-DMAC7.html) |
| EP (4) | EP2164458A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5628026B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100017667A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101677944A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008257505B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0812354A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2716159A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009012789A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2472492C2 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2008145732A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101729986B1 (ko) | 2006-09-22 | 2017-04-25 | 노보 노르디스크 에이/에스 | 프로테아제 내성 인슐린 유사체 |
| WO2008132224A2 (en) | 2007-04-30 | 2008-11-06 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| KR20100017667A (ko) * | 2007-06-01 | 2010-02-16 | 노보 노르디스크 에이/에스 | 안정한 비-수성의 약학 조성물 |
| WO2009112583A2 (en) * | 2008-03-14 | 2009-09-17 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| DK2910570T3 (en) | 2008-03-18 | 2017-01-30 | Novo Nordisk As | Protease-stabilized acylated insulin analogues. |
| WO2011033019A1 (en) * | 2009-09-16 | 2011-03-24 | Novo Nordisk A/S | Stable non-aqueous liquid pharmaceutical compositions comprising an insulin |
| CA2782056C (en) | 2009-11-25 | 2021-03-09 | Arisgen Sa | Mucosal delivery of peptides |
| MX2012007806A (es) * | 2010-01-12 | 2012-08-01 | Novo Nordisk As | Composiciones farmaceuticas para administracion oral de peptidos de insulina. |
| WO2011094632A1 (en) * | 2010-01-29 | 2011-08-04 | The Uab Research Foundation | Method for administration of insulin and pharmaceutical composition thereof |
| US20130157939A1 (en) * | 2010-08-23 | 2013-06-20 | Shmuel Ben-Sasson | Compositions for gastric delivery of active agents |
| EP2526971A1 (en) | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| US9481721B2 (en) | 2012-04-11 | 2016-11-01 | Novo Nordisk A/S | Insulin formulations |
| US8853189B2 (en) | 2012-05-31 | 2014-10-07 | Prima Innovations, Llc | Antispasmodic 1,2-Diols and 1,2,3-triols |
| US9956287B2 (en) | 2013-02-06 | 2018-05-01 | Perosphere Inc. | Stable glucagon formulations |
| MX366636B (es) | 2013-10-07 | 2019-07-17 | Novo Nordisk As | Nuevo derivado de un análogo de insulina. |
| EP2946788A1 (en) | 2014-05-23 | 2015-11-25 | Immundiagnostik AG | Method and composition for treating heart failure with preserved ejection fraction |
| EP3154568A4 (en) * | 2014-06-10 | 2018-01-24 | California Institute of Technology | Non-canonical insulins and their uses |
| ES2841933T3 (es) | 2014-10-31 | 2021-07-12 | Univ Monash | Formulación en polvo |
| TWI700091B (zh) | 2016-12-16 | 2020-08-01 | 丹麥商諾佛 儂迪克股份有限公司 | 含胰島素醫藥組成物 |
| US20200155648A1 (en) * | 2017-06-28 | 2020-05-21 | Children's Medical Center Corporation | Promoting lung growth |
| EP3915571A1 (en) * | 2020-05-29 | 2021-12-01 | Adocia | Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action |
| CN114432424B (zh) * | 2021-12-27 | 2023-06-27 | 南通联亚药业股份有限公司 | 一种稳定的铝塑包装去氨加压素片剂 |
| CN117045634B (zh) * | 2022-05-06 | 2025-10-10 | 北京康蒂尼药业股份有限公司 | 一种二肽衍生物组合物及其制备方法和用途 |
| EP4628092A1 (en) * | 2022-12-04 | 2025-10-08 | OOO "Geropharm" | Insulin aspart composition (embodiments) |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6074A (en) | 1849-01-30 | Machine fob making suspender-buckles | ||
| US4468A (en) | 1846-04-25 | Improvement in casting spoons | ||
| US3003A (en) * | 1843-03-17 | Improvement in the method of propelling vessels by means of continuous streams of water | ||
| US221A (en) | 1837-06-03 | Steam-boii | ||
| US2832685A (en) * | 1952-05-24 | 1958-04-29 | Crest Foods Co Inc | Solubilization of milk proteins |
| US3528960A (en) * | 1968-10-07 | 1970-09-15 | Lilly Co Eli | N-carboxyaroyl insulins |
| US3869437A (en) * | 1970-05-08 | 1975-03-04 | Nat Res Dev | Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin |
| US3950517A (en) * | 1970-05-08 | 1976-04-13 | National Research Development Corporation | Insulin derivatives |
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4033941A (en) * | 1975-12-17 | 1977-07-05 | Eli Lilly And Company | Process for purifying glucagon |
| JPS6030650B2 (ja) * | 1979-10-26 | 1985-07-17 | 日本油脂株式会社 | 座薬基剤組成物 |
| US4468221A (en) | 1981-04-10 | 1984-08-28 | Parker-Hannifin Corporation | Medication infusion pump |
| US4839341A (en) * | 1984-05-29 | 1989-06-13 | Eli Lilly And Company | Stabilized insulin formulations |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| US4719655A (en) * | 1986-01-21 | 1988-01-19 | Dean S Brooks | Invalid transfer device |
| US4849227A (en) * | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
| US5266310A (en) * | 1987-09-17 | 1993-11-30 | Boehringer Ingelheim International Gmbh | Stabilization of therapeutically active proteins in pharmaceutical preparations |
| DE3837825A1 (de) | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| HUT56857A (en) | 1988-12-23 | 1991-10-28 | Novo Nordisk As | Human insulin analogues |
| DE3844211A1 (de) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogues |
| US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
| AU628674B2 (en) * | 1989-10-19 | 1992-09-17 | Nippon Oil And Fats Company, Limited | Polymer complexes of a sugar response type |
| US5179189A (en) * | 1990-01-19 | 1993-01-12 | Nova Pharmaceutical Corporation | Fatty acid terminated polyanhydrides |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
| AU5171293A (en) * | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
| US5589167A (en) * | 1993-02-23 | 1996-12-31 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| DE69416409T2 (de) | 1993-06-21 | 1999-09-16 | Novo Nordisk A/S, Bagsvaerd | Asp-b28-insulinkristalle |
| US5506203C1 (en) * | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
| PT792290E (pt) | 1993-09-17 | 2002-01-30 | Novo Nordisk As | Insulina acilada |
| US6869930B1 (en) * | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
| US6011007A (en) | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
| US5504188A (en) | 1994-06-16 | 1996-04-02 | Eli Lilly And Company | Preparation of stable zinc insulin analog crystals |
| US6500645B1 (en) * | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| US5693609A (en) * | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
| US6251856B1 (en) * | 1995-03-17 | 2001-06-26 | Novo Nordisk A/S | Insulin derivatives |
| US20030104981A1 (en) * | 1995-11-03 | 2003-06-05 | Jelena Mandic | Human insulin analogues |
| US5858001A (en) | 1995-12-11 | 1999-01-12 | Elan Medical Technologies Limited | Cartridge-based drug delivery device |
| US6451970B1 (en) * | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
| US5981489A (en) * | 1996-07-18 | 1999-11-09 | Alza Corporation | Non-aqueous protic peptide formulations |
| EP0821006B1 (de) * | 1996-07-26 | 2004-04-21 | Aventis Pharma Deutschland GmbH | Insulinderivate mit erhöhter Zinkbindung |
| US5898067A (en) * | 1997-02-07 | 1999-04-27 | Novo Nordisk A/S | Crystallization of proteins |
| US5957895A (en) | 1998-02-20 | 1999-09-28 | Becton Dickinson And Company | Low-profile automatic injection device with self-emptying reservoir |
| TW570805B (en) * | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| US7030083B2 (en) * | 1998-09-09 | 2006-04-18 | University Of Washington | Treatment of eclampsia and preeclampsia |
| US6660715B2 (en) * | 1998-11-19 | 2003-12-09 | Massachusetts Institute Of Technology | Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
| US7425541B2 (en) * | 1998-12-11 | 2008-09-16 | Medarex, Inc. | Enzyme-cleavable prodrug compounds |
| WO2000047203A1 (en) * | 1999-02-12 | 2000-08-17 | Mqs, Inc. | Formulation and system for intra-oral delivery of pharmaceutical agents |
| CN1141974C (zh) * | 2000-06-07 | 2004-03-17 | 张昊 | 结肠定位释放的口服生物制剂 |
| US7060675B2 (en) * | 2001-02-15 | 2006-06-13 | Nobex Corporation | Methods of treating diabetes mellitus |
| US6867183B2 (en) * | 2001-02-15 | 2005-03-15 | Nobex Corporation | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith |
| CN1160122C (zh) * | 2001-04-20 | 2004-08-04 | 清华大学 | 一种制备口服胰岛素油相制剂的方法 |
| US6828297B2 (en) * | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| EP1423136A4 (en) * | 2001-08-10 | 2007-07-25 | Epix Pharm Inc | POLYPEPTIDE CONJUGATES HAVING INCREASED CIRCULATION HALF-VIES |
| US6770625B2 (en) * | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
| US7030082B2 (en) * | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
| AU2002314790A1 (en) * | 2001-12-05 | 2003-06-23 | Dow Global Technologies Inc. | Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications |
| UA46669C2 (uk) * | 2001-12-29 | 2005-12-15 | Товариство З Обмеженою Відповідальністю "Мако" | Спосіб приготування готової лікарської форми інсуліну пролонгованої дії |
| GB2386601B (en) | 2002-03-18 | 2005-12-21 | Bespak Plc | Seal material for a dispensing apparatus |
| WO2003105768A2 (en) * | 2002-06-13 | 2003-12-24 | Nobex Corporation | Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus |
| EP1545526A4 (en) * | 2002-09-17 | 2009-09-23 | Merck & Co Inc | REMOVAL OF ALDEHYDE POLLUTION BY REACTIVE POLYSTYRENE RESIN |
| JP2007524592A (ja) * | 2003-06-03 | 2007-08-30 | ノボ・ノルデイスク・エー/エス | 安定化された薬学的ペプチド組成物 |
| BRPI0413276B8 (pt) * | 2003-08-05 | 2021-05-25 | Novo Nordisk As | derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica |
| AU2004290862B2 (en) * | 2003-11-20 | 2010-06-03 | Novo Nordisk A/S | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| AU2004295023A1 (en) | 2003-12-03 | 2005-06-16 | Novo Nordisk A/S | Single-chain insulin |
| WO2005058961A2 (en) * | 2003-12-12 | 2005-06-30 | Amgen Inc. | Antibodies specific for human galanin, and uses thereof |
| KR20070044805A (ko) * | 2004-04-15 | 2007-04-30 | 키아스마, 인코포레이티드 | 생물학적 장벽 투과를 촉진시킬 수 있는 조성물 |
| WO2005115441A2 (en) * | 2004-05-10 | 2005-12-08 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| KR101309770B1 (ko) * | 2004-07-19 | 2013-09-30 | 바이오콘 리미티드 | 인슐린―올리고머 접합체,제형 및 이들의 용도 |
| JP2008510692A (ja) | 2004-08-20 | 2008-04-10 | ノボ ノルディスク アクティーゼルスカブ | 薬学的に活性なインスリン受容体調節分子 |
| AU2006235183B2 (en) * | 2005-04-08 | 2011-02-10 | Amylin Pharmaceuticals, Llc | Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent |
| WO2007004948A1 (en) * | 2005-06-30 | 2007-01-11 | Astrazeneca Ab | Environmental detector |
| US20100210506A1 (en) * | 2005-10-20 | 2010-08-19 | Mdrna, Inc. | Intranasal administration of rapid acting insulin |
| KR101729986B1 (ko) | 2006-09-22 | 2017-04-25 | 노보 노르디스크 에이/에스 | 프로테아제 내성 인슐린 유사체 |
| KR20100017667A (ko) * | 2007-06-01 | 2010-02-16 | 노보 노르디스크 에이/에스 | 안정한 비-수성의 약학 조성물 |
| US20090087484A1 (en) * | 2007-09-28 | 2009-04-02 | Alza Corporation | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| US20110293714A1 (en) * | 2008-11-28 | 2011-12-01 | Novo Nordisk A/S | Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides |
-
2008
- 2008-05-30 KR KR1020097025474A patent/KR20100017667A/ko not_active Abandoned
- 2008-05-30 EP EP08760278A patent/EP2164458A1/en not_active Withdrawn
- 2008-05-30 BR BRPI0812354-3A2A patent/BRPI0812354A2/pt not_active Application Discontinuation
- 2008-05-30 EP EP08760287A patent/EP2164459A1/en not_active Withdrawn
- 2008-05-30 JP JP2010509834A patent/JP5628026B2/ja not_active Expired - Fee Related
- 2008-05-30 RU RU2009146883/15A patent/RU2472492C2/ru not_active IP Right Cessation
- 2008-05-30 AU AU2008257505A patent/AU2008257505B2/en not_active Ceased
- 2008-05-30 CN CN200880017599A patent/CN101677944A/zh active Pending
- 2008-05-30 MX MX2009012789A patent/MX2009012789A/es active IP Right Grant
- 2008-05-30 US US12/601,345 patent/US20100190706A1/en not_active Abandoned
- 2008-05-30 EP EP12159419A patent/EP2514407A1/en not_active Withdrawn
- 2008-05-30 EP EP12159415A patent/EP2497462A1/en not_active Withdrawn
- 2008-05-30 CA CA2716159A patent/CA2716159A1/en not_active Abandoned
- 2008-05-30 WO PCT/EP2008/056699 patent/WO2008145732A1/en not_active Ceased
- 2008-05-30 JP JP2010509835A patent/JP5675347B2/ja not_active Expired - Fee Related
- 2008-05-30 WO PCT/EP2008/056689 patent/WO2008145730A1/en not_active Ceased
- 2008-05-30 US US12/601,884 patent/US20100144592A1/en not_active Abandoned
-
2014
- 2014-07-21 US US14/336,562 patent/US20140349924A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010529004A5 (cg-RX-API-DMAC7.html) | ||
| RU2470016C2 (ru) | Производное бипиразола | |
| CN114901280B (zh) | MrgprX2拮抗剂及其用途 | |
| US10052333B2 (en) | Methods and systems for the delivery of a therapeutic agent | |
| WO2006037342A3 (en) | Controlled release pharmaceutical compositions comprising a fumaric acid ester | |
| EP2011487A3 (en) | Pharmaceutical compositions for gastroinetestinal drug delivery | |
| CA2676010C (en) | Methods and compositions for the delivery of a therapeutic agent | |
| JP2009102342A5 (cg-RX-API-DMAC7.html) | ||
| WO2007123955A3 (en) | Stable hydroalcoholic oral spray formulations and methods | |
| WO2009050738A3 (en) | An orally administerable solid pharmaceutical composition and a process thereof | |
| JP2015517478A5 (cg-RX-API-DMAC7.html) | ||
| WO2009033131A3 (en) | Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin | |
| RU2009110452A (ru) | Галеновые составы алискирена | |
| CA2671470A1 (en) | Powder formulation for valganciclovir | |
| RU2020109881A (ru) | Агонисты рецепторов glp-1/глюкагона в лечении жировой болезни печени и стеатогепатита | |
| JP2004505036A5 (cg-RX-API-DMAC7.html) | ||
| EP2895147B1 (en) | Rapidly dissolving pharmaceutical composition | |
| CN114929283A (zh) | 肽和多糖的新缀合物 | |
| JP2009541455A5 (cg-RX-API-DMAC7.html) | ||
| WO2007087344A3 (en) | Anti-histamine compositions and use thereof | |
| JP2008512429A (ja) | ロフルミラストとsykインヒビターとの組合せ物並びにその使用方法 | |
| WO2008065144A3 (en) | Galenic formulations of organic compounds | |
| KR102351813B1 (ko) | 탄닌산 시타글립틴 복합체 | |
| CN1678334A (zh) | 新型的作为药物和营养制品的生物利用率或生物功效增强剂的基于植物的试剂 | |
| CN114728919B (zh) | MrgprX2拮抗剂及其用途 |